Recombinant Human NY-ESO-1 (HLA-A*02:01) Protein, His-Avi Tag

Description :
FAQ COA 已发表文献 NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy. 产品性质 Synonyms MHC; MY-ESO-1; CT6.1; LAGE-2; CTAG1; CTAG1B; ESO1CTAG; LAGE2A; NY-ESO-1 Uniprot No. A0A140T913(HLA-A*02:01)&P61769(B2M)&SLLMWITQC Source Recombinant Human NY-ESO-1 (HLA-A*02:01) Protein is expressed from HEK293 Cells with His tag and Avi tag at the C-terminal.It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and SLLMWITQCpeptide. Molecular Weight The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 51-60 kDa based on Tris-Bis PAGE result. Purity > 95% as determined by SDS-PAGE and HPLC Endotoxin 1.0EU per 1g of the protein by the LAL method. Formulation Supplied as 0.22m filtered solution in PBS, 100mM L-arginine (pH 7.4).